Status:

RECRUITING

Short-course Radiotherapy (5×6Gy/7Gy/8Gy) Followed by Neo-adjuvant Chemotherapy for Locally Advanced Rectal Cancer

Lead Sponsor:

Fujian Medical University Union Hospital

Conditions:

Radiation Oncology

Rectal Cancer

Eligibility:

All Genders

18-70 years

Brief Summary

Preoperative radiotherapy followed by total mesorectal excision (TME) has been recommended as the preferred treatment method for locally advanced rectal cancer. Similar rates of local control, surviva...

Detailed Description

Rectal cancer is one of the most common malignant tumors in western countries and its incidence and mortality rates have been ascending for several decades in our country. Surgical resection is the pr...

Eligibility Criteria

Inclusion

  • Previously untreated, biopsy-proven stage T3-4 and/or N+,resectable rectal adenocarcinoma with the tumors near anal verge within 12 cm;
  • Male or non-pregnant female;
  • Between 18 and 70 years of age;
  • Adequate hematologic function: white blood cell(WBC) counts≥4,000/mm3, neutrophils counts ≥ 1,500/mm3, platelet counts ≥ 100,000/µL, hemoglobin ≥ 9g/L;
  • Adequate renal function: creatinine ≤ 1.5×upper normal limit;
  • Adequate hepatic function: total bilirubin, glutamic oxalacetic transaminase, glutamate pyruvate transaminase level \< 2.0×upper normal limit);
  • Satisfactory performance status: Karnofsky Performance Status(KPS)≥70;
  • Approval from the ethics committee and prior written informed consents from all patients before registration were obtained.

Exclusion

  • the evidence of relapse or distant metastasis;
  • receiving treatment of other anti-cancer drugs or methods;
  • Patients have low compliance and are not able to complete the entire trial;
  • the presence of uncontrolled life-threatening diseases;
  • dysfunction of heart, brain, lung and et al.

Key Trial Info

Start Date :

August 1 2022

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 1 2026

Estimated Enrollment :

9 Patients enrolled

Trial Details

Trial ID

NCT03466424

Start Date

August 1 2022

End Date

December 1 2026

Last Update

February 16 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Fujian Medical University Union Hospital

Fuzhou, Fujian, China, 350000

Short-course Radiotherapy (5×6Gy/7Gy/8Gy) Followed by Neo-adjuvant Chemotherapy for Locally Advanced Rectal Cancer | DecenTrialz